Abstract:
A method and system for private shipping to anonymous users purchasing goods on a computer or communications network linking users with merchant web-sites for electronic commerce. In a preferred embodiment, a user is issued a proxy identity and the user's mailing address is received and encrypted. The proxy identity and encrypted mailing address are transmitted to a merchant, and decryption information is provided to a shipper. Upon receipt of the encrypted shipping address from the merchant, the shipper can use the decryption information to decrypt the address and generate a package label bearing the true shipping address of the user so that the merchant is prevented from electronically capturing the true identity of the user. The present invention provides for anonymity of a user when browsing and shopping, and integrates easily and simply with existing online infrastructures of banks or credit card issuers, and delivery companies.
Abstract:
A process for the preparation of substituted halogenated anilines from substituted halogenated 1-chlorobenzenes which comprisesa) reacting a substituted halogenated 1-chlorobenzene selectively with an imine in the presence of a transition metal catalyst complex and a base to form an N-aryl imine; b) hydrolyzing the N-aryl imine; andc) isolating the substituted halogenated aniline.
Abstract:
The present invention provides a new solution to reliable communication between automobiles and other communications devices. It relies on multiple available wireless bands and the addition of significant memory buffering to automobiles. The memory buffering is used to enable a new communications model for messages that we call Mobile Message Memory Queues (M3Qs). A significant benefit of the disclosed invention is the ease in which it can be incorporated into an automobile.
Abstract:
Provided herein methods for determining whether a subject, particularly a human subject, is at risk of developing, having, or experiencing a complication of cardiovascular disease, and methods of treating subjects who are identified by the current methods of being at risk for cardiovascular disease. In one embodiment, the method comprises determining levels of one or more oxidized apolipoprotien A-I related biomolecules in a bodily sample from the subject. Also, provided are kits and reagents for use in the present methods. Also provided are methods for monitoring the status of cardiovascular disease in a subject or the effects of therapeutic agents on subjects with cardiovascular disease. Such method comprising determining levels of one or more oxidized apolipoprotein A-I related molecules in bodily samples taken from the subject over time or before and after therapy.
Abstract:
The inventive subject matter relates to an immunogenic composition and method of immunizing a subject against malarial disease comprising administering to the subject a priming immunization preparation comprising alphavirus replicons expressing a gene encoding a malarial antigen or combination of malarial antigens and subsequently administering to the subject a boosting immunization preparation comprising the malarial antigen(s) or an expression system containing the antigen(s). The inventive composition and methods result in a robust induction of humoral and cellular immune system responses, including CD8+, CD4+ and antibody responses.
Abstract:
A motor vehicle door hinge with a hinge axis includes a first hinge part and a second hinge part. The first hinge part has a first arm and a second arm axially spaced from the first arm with the hinge axis passing through the first arm and the second arm. The second hinge part includes a continuous strip of material having a first end, a second end, and a bent section between the first end and second end. The bent section is disposed between the first arm and second arm about the hinge axis. The first end has a first section and the second end has a second section. The first section and second section are parallel and fixed relative to each other.
Abstract:
A rotary retort furnace wherein the retort is supported for rotation at only one end outside of the heated furnace shell such that the retort is cantilevered into the shell. The rotary retort has a charging door mechanism that cooperates with a skip hoist loading mechanism to provide charges of the parts to be heat treated that are of a uniform size and are introduced into the retort so as to minimize the loss of any controlled atmosphere. The skip hoist loading mechanism has a vibrating feed hopper that dispenses a weight controlled charge into a skip hoist bucket which, after receiving the predetermined charge of parts, is held in a ready position until such time as a cam mechanism controlling the opening and closing of a door on the charge end of the retort causes the door to open and the skip bucket to be moved to a position wherein the parts are dumped into the retort for heat treating. The internal auger flight for the retort is made by forming a number of toroids from a resilient material, radially cutting each of the toroids and deforming them to form individual flights, and connecting one of the split edges resulting from the cutting to the opposite edge of an adjacent flight such that an axially compressed helical subassembly is obtained. The helical subassembly is then screwed onto a shaft having a number of guide pins axially on the shaft at predetermined spacings thereby both axially extending and radially compressing the helical subassembly. The shaft and the helical subassembly are inserted into a retort shell and one free end of the subassembly is welded to one end of the retort. The shaft is then unscrewed from the subassembly while at the same time being forced axially into the retort such that the edges of the helical subassembly fit tightly against the inside of the retort. After the shaft has been removed, the remaining end of the helical subassembly is welded to the end of the retort.
Abstract:
A rotary retort furnace wherein the retort is supported for rotation at only one end outside of the heated furnace shell such that the retort is cantilevered into the shell. The rotary retort has a charging door mechanism that cooperates with a skip hoist loading mechanism to provide charges of the parts to be heat treated that are of a uniform size and are introduced into the retort so as to minimize the loss of any controlled atmosphere. The skip hoist loading mechanism has a vibrating feed hopper that dispenses a weight controlled charge into a skip hoist bucket which, after receiving the predetermined charge of parts, is held in a ready position until such time as a cam mechanism controlling the opening and closing of a door on the charge end of the retort causes the door to open and the skip bucket to be moved to a position wherein the parts are dumped into the retort for heat treating. The internal auger flight for the retort is made by forming a number of toroids from a resilient material, radially cutting each of the toroids and deforming them to form individual flights, and connecting one of the split edges resulting from the cutting to the opposite edge of an adjacent flight such that an axially compressed helical subassembly is obtained. The helical subassembly is then screwed onto a shaft having a number of guide pins axially on the shaft at predetermined spacings thereby both axially extending and radially compressing the helical subassembly. The shaft and the helical subassembly are inserted into a retort shell and one free end of the subassembly is welded to one end of the retort. The shaft is then unscrewed from the subassembly while at the same time being forced axially into the retort such that the edges of the helical subassembly fit tightly against the inside of the retort. After the shaft has been removed, the remaining end of the helical subassembly is welded to the end of the retort.
Abstract:
Provided herein methods for determining whether a subject, particularly a human subject, is at risk of developing, having, or experiencing a complication of cardiovascular disease, and methods of treating subjects who are identified by the current methods of being at risk for cardiovascular disease. In one embodiment, the method comprises determining levels of one or more oxidized apolipoprotein A-I related biomolecules in a bodily sample from the subject. Also, provided are kits and reagents for use in the present methods. Also provided are methods for monitoring the status of cardiovascular disease in a subject or the effects of therapeutic agents on subjects with cardiovascular disease. Such method comprising determining levels of one or more oxidized apolipoprotein A-I related molecules in bodily samples taken from the subject over time or before and after therapy.